|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/564 | (2006.01) |
| G01N 33/564 | (2013.01) | ||
| G01N 33/68 | (2006.01) | ||
| G01N2800/52 | (2013.01) | ||
| G01B 5/00 | (2006.01) | ||
| G01N2800/56 | (2013.01) | ||
| G01N2800/104 | (2013.01) | ||
| G16H 50/20 | (2018.01) | ||
| G01N2333/52 | (2013.01) | ||
| G16H 50/30 | (2018.01) | ||
| Y02A 90/10 | (2018.01) |
| (11) | Number of the document | 3867645 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19873181.2 |
| Date of filing the European patent application | 2019-09-25 | |
| (97) | Date of publication of the European application | 2021-08-25 |
| (45) | Date of publication and mention of the grant of the patent | 2024-06-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/052917 |
| Date | 2019-09-25 |
| (87) | Number | WO 2020/081204 |
| Date | 2020-04-23 |
| (30) | Number | Date | Country code |
| 201862747455 P | 2018-10-18 | US |
| (72) |
JAMES, Judith Ann , US
MUNROE, Melissa Elizabeth , US
|
| (73) |
Oklahoma Medical Research Foundation ,
825 N.E. 13th Street, Oklahoma City, OK 73104,
US
|
| (54) | BIOMARKERS FOR A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) DISEASE ACTIVITY IMMUNE INDEX THAT CHARACTERIZES DISEASE ACTIVITY |
| BIOMARKERS FOR A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) DISEASE ACTIVITY IMMUNE INDEX THAT CHARACTERIZES DISEASE ACTIVITY |